description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CACTTGCCCATTGAGAACCTAAAGCCCAACACGAGGTATTATTTTAAAGTGCAAGCACAAAATCCTCATGGCTACGGACCTATCAGCCCTTCGGTCTCATTTGTCACCGAATCAGATAATCCTCTGCTTGTTGTGAGGCCCCCAGGCGGTGAGCCTATCTGGATCCCATTCGCTTTCAAACATGATCCCAGCTACACGGACTGCCATGGACGGCAATATGTGAAGCGCACGTGGTATCGAAAGTTCGTGGGAGTTGTTCTTTGTAATTCACTGAGGTATAAAATCTACCTCAGTGACAACCTGAAAGATACATTCTACAGCATTGGAGACAGCTGGGGAAGAGGTGAAGACCATTGCCAATTTGTGGATTCACACCTTGATGGAAGAACAGGGCCTCAGTCCTATG
Ensembl | human accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... FNDC1(84624)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Hisaki Hayashi et al.
Scientific reports, 9(1), 1560-1560 (2019-02-09)
Choroidal neovascularization (CNV) is associated with age-related macular degeneration (AMD), a major cause of vision loss among elderly people. Vascular endothelial cell growth factor (VEGF) is essential for the development and progression of AMD, and VEGF signaling molecules are effective
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU077341-20UG | 04061828628544 |
| EHU077341-50UG | 04061828400881 |